Hospira Buprenorphine Hydrochloride Injection and Labetalol Hydrochloride Injection - recalled due to Packaging Defect, USA
5 days ago •source fda.gov • details
Recall notice
3 years ago • business
Regulatory Report
260 Lenoir Drive, Winchester, 22603 Virginia, United States
The employer has not implemented any of the requirements of the VOSH COVID-19 TES in the work place, including staff and employees and customers not wearing face coverings, not conducting daily sanitizing of tools and work stations, not having sanitizing supplies available, having no COVID-19 Written Protection Program, with a risk hazard assessment, and employee training.5 days ago •source fda.gov • details
Recall notice
1 week ago •reported by user-gpwcc217 • details
2 weeks ago •reported by user-xbvp3431 • details
2 weeks ago •reported by user-xmwnx654 • details
1 week ago •reported by user-cwnw7178 • details
2 weeks ago •reported by user-ffwz6956 • details
5 days ago •reported by user-jwjzz494 • details
2 weeks ago •reported by user-gztzt977 • details
3 days ago •reported by user-bqbw4813 • details
2 weeks ago •reported by user-hccjy754 • details
Search